health
machines without manuals
Africa's laboratory networks have hardware without the quality management systems needed to use it
Problem statement
African health systems saw new diagnostic technologies introduced over the decade to 2020, such as rapid tests and point-of-care molecular instruments, but the quality management systems required to generate reliable, accreditable results from them were not built alongside. Around 430 laboratories implementing quality management systems had been assessed under the SLIPTA programme since its launch in 2012, against an original target of 2,500 enrolled laboratories. The result is a continent where physical equipment exists but cannot be trusted to produce results that translate into clinical decisions or epidemiological surveillance.
Why this matters
The distribution of accredited labs reveals the structural failure: more than 370 of Africa's roughly 520 accredited laboratories are in South Africa alone, meaning the 54 remaining AU member states share fewer than 150 accredited facilities. When the first African case of SARS-CoV-2 was reported, only 2 of 55 countries had the diagnostic capacity to detect it independently. Ethiopia illustrates the workforce dimension: it would need an estimated 4,209 pathologists to match the United States ratio of pathologists to population, and had 61 as of August 2019.
What’s been tried and why it hasn’t worked
Investment in African diagnostics has been concentrated in disease-specific vertical programmes such as HIV and tuberculosis, while national tiered laboratory networks have generally remained underfunded. Diagnostics were introduced at the site level without enough attention to the laboratory systems underneath them, such as supply chain, workforce and finance. The SLIPTA (Stepwise Laboratory Quality Improvement Process Towards Accreditation) framework exists and is used, but uptake has been slow. The source points to a lack of core funding for the programme, which leaves too little capacity to audit and mentor laboratories, and to low political commitment and missing national policy frameworks in some countries. Specimen referral systems remain fragmented by disease programme rather than organized as national tiered networks, so samples that cannot be tested locally often have no clear referral pathway. New diagnostic technologies continue to be introduced without commensurate investment in the quality management, maintenance, and workforce training that would make them functional.
What would unlock progress
The tiered laboratory network model — national reference labs, regional hubs, peripheral facilities, with defined specimen referral pathways between them — is understood and has been implemented partially in some countries. Scaling it requires a workforce development pipeline that produces laboratory quality managers, not just laboratory technicians. It also requires converting disease-specific vertical infrastructure into shared horizontal capacity, which is a coordination and political problem as much as a technical one. Standardized quality management toolkits adapted for low-resource settings, combined with regional peer-accreditation support, could reduce the time and cost of moving individual labs through SLIPTA steps.
Entry points for student teams
A systems design team could map the tiered network architecture problem in a specific country context: what referral pathways exist, where they break, and what minimum structural changes would create a functional national network. A workforce modelling team could estimate the pathologist and lab quality manager deficit across the continent by country and project what training pipeline investment would close it at different time horizons. A process team could analyze the SLIPTA step distribution across African labs to identify which quality management steps are most commonly stalled and what interventions have moved labs past those steps.
Genes
Structural cousins: stuck the same way, in other fields
Sources
Ondoa P, Ndlovu N, Keita M-S, et al., "Preparing national tiered laboratory systems and networks to advance diagnostics in Africa and meet the continent’s health agenda: Insights into priority areas for improvement," Afr J Lab Med, 2020;9(2), a1103, Africa CDC, "Africa requires skills to plug gaps in diagnostic capacity and disease surveillance," 8 November 2024, (accessed 2026-02-23) go to source 1 ↗ go to source 2 ↗
Working notes
Notes made while writing and checking this brief, shown as written. They use working shorthand.
Primary sources are Africa CDC's diagnostic capacity assessment and the PMC-indexed analysis of national tiered laboratory systems, both produced by or in direct collaboration with Africa CDC and the African Society for Laboratory Medicine (ASLM). These are institutional assessments authored by the continent's primary laboratory medicine bodies.
Source type: Self-articulated
Reconciliation 2026-09-29: Both cited sources were fetched and read in full on 2026-09-29. The journal article was read at https://pmc.ncbi.nlm.nih.gov/articles/PMC7565058/ and again as full text from Europe PMC. The Africa CDC news story was read at the address in the Source line. Changes: (1) The Source line gave the article's title as "Preparing national tiered laboratory systems in Africa for COVID-19 and beyond." The page gives a different title, and the Source line now carries the title, authors and journal reference copied from the page's "How to cite this article" line. The Africa CDC item now carries its headline and its date, 8 November 2024. The links are unchanged. (2) The text said "only 430 of a target 2,500 laboratories have implemented quality management systems meeting international standards." The article says around 430 laboratories implementing quality management systems have been assessed under SLIPTA since 2012, against an original target of 2,500 enrolled laboratories. Being assessed is not the same as meeting the standard, and the sentence now says what the article says. (3) The text said health systems had received hardware investment over two decades and named PCR machines, biosafety cabinets and sequencers. Neither source says this. The article, published in 2020, says new technologies were introduced over the past decade and names rapid tests and point-of-care molecular instruments. The sentence now says that, and dates the decade to 2020. (4) The text said 370 of 520 accredited laboratories are in South Africa, leaving 150 for the rest. The article says "around 520" and "more than 370", so the sentence now says more than 370 of roughly 520, and fewer than 150 for the rest. (5) A sentence said Guinea's 2014 Ebola outbreak went unidentified for three months as a direct consequence of missing laboratory capacity. Neither source mentions Guinea or this delay, so the sentence was removed. (6) The text said Ethiopia needs 4,209 pathologists "to meet population needs" and "currently has 61". Table 3 of the article gives 4,209 as the number needed to match the United States ratio, and 61 as the count in August 2019. The sentence now says both. (7) The text described equipment donation, separate laboratory networks for HIV, TB, malaria and polio, and machines that cannot share reagents or maintenance contracts. Neither source says this. The article says investment went to selected disease programmes such as HIV and tuberculosis while national networks stayed underfunded, and that diagnostics were introduced at site level without enough attention to the systems underneath. The two sentences now say that, and the closing sentence of the section says "new diagnostic technologies" where it said "hardware donations". (8) The text spelled out SLIPTA without the word "Quality" and said uptake was slow because most facilities lack management capacity. The article's name for the programme is Stepwise Laboratory Quality Improvement Process Towards Accreditation. The reasons it gives for slow uptake are a lack of core funding, too little capacity to audit and mentor, low political commitment and missing national policy frameworks. The text now gives the full name and those reasons. Confirmed against the article and left as written: only 2 of 55 countries could detect SARS-CoV-2 when the first case was reported, in Egypt in February 2020; specimen transport systems that are fragmented by disease programme and funded by different donors; a few countries with integrated referral networks; test results that clinicians and communities do not trust; authorship by staff of the African Society for Laboratory Medicine and Africa CDC. The main title and the short title were left as written. They describe laboratories as having hardware, which is a stronger statement than the article makes, since the article also reports gaps in testing equipment. The sections on what would unlock progress and on entry points for student teams are the write-up's own advice and were not changed. Genes untouched.